153 related articles for article (PubMed ID: 18270138)
1. Bovine mesenteric venous graft as an alternative conduit in patients with cyanotic heart disease with e-polytetrafluoroethylene graft failure caused by thrombophilic factor positivity after modified Blalock-Taussig shunt.
Akbulut B; Dogan OF; Guvener M; Yilmaz M; Yorgancioglu C; Karagoz T; Ozkutlu S; Demircin M; Dogan R
Heart Surg Forum; 2008; 11(1):E37-41. PubMed ID: 18270138
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia.
Azboy D; Temiztürk Z
Heart Surg Forum; 2020 Oct; 23(6):E718-E724. PubMed ID: 33234223
[TBL] [Abstract][Full Text] [Related]
3. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease.
Sahoo TK; Chauhan S; Sahu M; Bisoi A; Kiran U
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):179-83. PubMed ID: 17418728
[TBL] [Abstract][Full Text] [Related]
4. Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates.
Ahmad U; Fatimi SH; Naqvi I; Atiq M; Moizuddin SS; Sheikh KB; Shahbuddin S; Naseem TM; Javed MA
Heart Lung Circ; 2008 Feb; 17(1):54-8. PubMed ID: 17683985
[TBL] [Abstract][Full Text] [Related]
5. The modified Blalock-Taussig shunt: a 6-year experience from a developing country.
Maghur HA; Ben-Musa AA; Salim ME; Abuzakhar SS
Pediatr Cardiol; 2002; 23(1):49-52. PubMed ID: 11922508
[TBL] [Abstract][Full Text] [Related]
6. [Long-term patency after the Blalock-Taussig operation--comparison between classic and modified shunts].
Ohuchi H; Okabe H; Nagata N; Koseni K; Kaneko Y; Itoh K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Aug; 44(8):1108-13. PubMed ID: 8828367
[TBL] [Abstract][Full Text] [Related]
7. Early and late results of the modified Waterston shunt with PTFE grafts for palliation of complex congenital cyanotic heart disease in neonates.
Fenchel G; Steil E; Seboldt H; Quintenz R; Apitz J; Hoffmeister HE
Thorac Cardiovasc Surg; 1991 Oct; 39(5):268-72. PubMed ID: 1785113
[TBL] [Abstract][Full Text] [Related]
8. Modified Blalock-Taussig shunts: to heparinize or not to heparinize?
Mullen JC; Lemermeyer G; Bentley MJ
Can J Cardiol; 1996 Jul; 12(7):645-7. PubMed ID: 8689534
[TBL] [Abstract][Full Text] [Related]
9. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt.
Tabbutt S; Dominguez TE; Ravishankar C; Marino BS; Gruber PJ; Wernovsky G; Gaynor JW; Nicolson SC; Spray TL
Ann Thorac Surg; 2005 Nov; 80(5):1582-90; discussion 1590-1. PubMed ID: 16242421
[TBL] [Abstract][Full Text] [Related]
10. Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts.
Sivakumar K; Shivaprakasha K; Rao SG; Kumar RK
Indian Heart J; 2001; 53(1):66-70. PubMed ID: 11456144
[TBL] [Abstract][Full Text] [Related]
11. [Calcified EPTFE vascular prosthesis in the Blalock-Taussig shunt after 4 years of implantation: a case report].
Takanashi Y; Tomizawa Y; Noishiki Y; Yoshihara K
Kyobu Geka; 1997 Jan; 50(1):71-3. PubMed ID: 8990814
[TBL] [Abstract][Full Text] [Related]
12. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.
de Leval MR; McKay R; Jones M; Stark J; Macartney FJ
J Thorac Cardiovasc Surg; 1981 Jan; 81(1):112-9. PubMed ID: 6450303
[TBL] [Abstract][Full Text] [Related]
13. Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome.
Tsai KT; Chang CH; Lin PJ
J Cardiovasc Surg (Torino); 1996 Apr; 37(2):149-52. PubMed ID: 8675521
[TBL] [Abstract][Full Text] [Related]
14. Criterions for selection of patients for, and results of, a new technique for construction of the modified Blalock-Taussig shunt.
Chowdhury UK; Venugopal P; Kothari SS; Saxena A; Talwar S; Subramaniam G; Singh R; Pradeep KK; Sathia S; Kumar AS
Cardiol Young; 2006 Oct; 16(5):463-73. PubMed ID: 16984698
[TBL] [Abstract][Full Text] [Related]
15. Outcome of the construction of a Blalock-Taussig shunt in adolescents and adults.
Peries A; Al-Hay AA; Shinebourne EA
Cardiol Young; 2005 Aug; 15(4):368-72. PubMed ID: 16014183
[TBL] [Abstract][Full Text] [Related]
16. Systemic pulmonary shunt performed with Shelhigh internal mammary artery: early results.
Poyrazoglu HH; Avşar MK; Tor F; Erdem S; Göçen U; Bayraktar I; Kayhan C; Ozbarlas N; Salih OK
Heart Surg Forum; 2008; 11(1):E50-3. PubMed ID: 18270142
[TBL] [Abstract][Full Text] [Related]
17. Systemic pulmonary artery shunt using a bovine mesenteric venous graft in newborns.
Kalangos A; Beghetti M; Pache JC; Vala D; Faidutti B
J Card Surg; 2000; 15(4):239-43. PubMed ID: 11758058
[TBL] [Abstract][Full Text] [Related]
18. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation.
Wells WJ; Yu RJ; Batra AS; Monforte H; Sintek C; Starnes VA
Ann Thorac Surg; 2005 Jun; 79(6):2072-6. PubMed ID: 15919312
[TBL] [Abstract][Full Text] [Related]
19. The Blalock-Taussig shunt.
Yuan SM; Shinfeld A; Raanani E
J Card Surg; 2009; 24(2):101-8. PubMed ID: 19040408
[TBL] [Abstract][Full Text] [Related]
20. [Perioperative management of systemic pulmonary shunts in the neonatal period].
González de Dios J; Blanco Bravo D; Burgueros Valero M; Cordovilla Zurdo G; Pérez Rodríguez J; García Guereta L; Quero Jiménez J
An Esp Pediatr; 1993 Aug; 39(2):139-48. PubMed ID: 8239209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
